Relationship between race, income-level, and Cardiovascular Disease.

Talha KM, Waqar E, Johnson HM, Shapiro MD, Nambi V, Virani SS, Mehta A, Nasir K, Hall ME, Abramov D, Minhas AMK

Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both.

Zhou XD, Lonardo A, Pan CQ, Shapiro MD, Zheng MH, WMU MAFLD Clinical Research Working Group

Familial Hypercholesterolemia: Genes and Beyond.

Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Warden BA, Fazio S, Shapiro MD

Between the Extremes: The Impact of Lipid Variability on Cardiovascular Risk.

Shapiro MD

Self-rated health and risk of incident cardiovascular events among individuals with hypertension.

Kazibwe R, Muhammad AI, Singleton MJ, Evans JK, Chevli PA, Namutebi JH, Kazibwe J, Epiu I, German C, Soliman EZ, Shapiro MD, Yeboah J

Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction-associated fatty liver disease: An exploratory study.

Zhou XD, Xu CF, Chen QF, Shapiro MD, Lip GYH, Chen LL, Targher G, Byrne CD, Tian N, Xiao T, Huang CX, Ni Y, Zheng MH

Sarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome.

Mirzai S, Carbone S, Batsis JA, Kritchevsky SB, Kitzman DW, Shapiro MD

ASPC President's page: Advancing preventive cardiology together.

Shapiro MD

Therapeutic Gene Editing in Dyslipidemias.

Tamehri Zadeh SS, Shapiro MD

Bempedoic Acid in Secondary Prevention.

Mousavi I, Nambi V, Abushamat LA, Al-Kindi SG, Shapiro MD, Sperling L, Virani SS, Minhas AMK